Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, April 17, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Cellexus Launches the New CellMaker PLUS
Friday, November 29, 2013
A highly flexible, robust single-use bioreactor system with full pH and DO control to provide high ODs and yields of soluble protein.

GE Healthcare Life Sciences Next-Generation, Single-Use, Rocking Bioreactor System
Monday, November 18, 2013
ReadyToProcess WAVE™* 25 bioreactor system is an intuitive and easy-to-use cell culture device with advanced functionality designed to meet the evolving needs of bioprocessing.

Plasticell Announces CombiCult Patents
Monday, November 18, 2013
Additional family of CombiCult® patents granted in USA, Europe, Australia and Singapore.

Plasticell Announces CombiCult Patents
Monday, November 18, 2013
Additional family of CombiCult® patents granted in USA, Europe, Australia and Singapore.

ZEISS Introduces New Technology for 3D Superresolution Microscopy
Thursday, November 14, 2013
Photoactivated localization microscopy (PALM) in 3D with ZEISS ELYRA.

Oxford Optronix Launches HypoxyLab™
Thursday, November 14, 2013
HypoxyLab™ provides a physiologically reproducible, contamination-free, low oxygen/hypoxia environment to create optimal conditions for life science and clinical medicine research.

Compact All-in-One Multiple Format Mixer
Tuesday, November 12, 2013
An accurate, reliable, compact and simple-to-use multi-format mixer.

Asylum Research Introduces blueDrive™ Photothermal Excitation
Friday, November 08, 2013
For atomic force microscopy imaging and nanomechanics.

Scientists at the London Research Institute of CRUK Use the Linkam CMS196
Thursday, November 07, 2013
Scientists use CMS196 stage for the imaging of mammalian cells with Cryo-CLXM microscopy.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 189
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv